longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CSPC Innovation

300765

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 59.76, above the reasonable range, cheaper than 16.65% of the time in the past 5 years, and the industry ranks 109/221, the industry Median 23.14.

59.76xP/E
¥43.52Stock price
¥0.73Earnings per share
59.76xP/E
Stock price¥43.52Earnings per share¥0.73

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
18.83x
Typical range
-185.92x–55.86x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.14x
020406080

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.14x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
300765SZCSPC Innovation
59.76x715.52%¥61.13B
002294SZSalubris
50.07x29.31%¥33.72B
300558SZBETTA PHARMACEUTICALS
42.32x90.41%¥19.79B
002755SZASK PHARM
53.64x--¥10.58B
300725SZPHARMABLOCK
49.44x18.18%¥10.42B
000756SZXinhua Pharm
42.07x--¥9.06B
600789SHLKPC
55.16x--¥7.92B
600195SHCAHIC
50.18x19.19%¥6.99B
301393SZHighfine
56.82x--¥6.22B
002390SZxinbang phar.
51.93x--¥5.85B
002940SZALK
41.53x--¥4.75B
301509SZKingchem
53.26x--¥3.37B
603079SHSHENGDA BIO-PHARM
54.08x--¥2.43B
600851SHHX GROUP
51.13x--¥10.12B
900904SHShenqi
58.06x--¥237.13M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.